Archives
-
SU6656 Src Tyrosine Kinases Inhibitor Guide
2026-09-30
SU6656 is a Src tyrosine kinases inhibitor used to study PDGF/Src signaling, megakaryocyte polyploidization, and tumor vascular responses to irradiation. Product data support its DMSO formulation and storage requirements, while the 2026 hiPSC platelet study provides a benchmark for small-molecule optimization without establishing SU6656 as the cause of its reported yield.
-
METTL14–SMN Signaling in m6A Homeostasis
2026-09-30
The reference study identifies SMN as an interaction partner of the m6A methyltransferase component METTL14 and shows that this association depends on arginine methylation. Its findings connect SMN Tudor-domain mutations in spinal muscular atrophy with altered m6A deposition, impaired DNA-repair gene expression, and sensitivity to DNA damage, while a methylation-deficient Mettl14 mouse model reveals developmental and hematopoietic consequences.
-
D-Luciferin Potassium Salt for Bioluminescence Imaging
2026-09-29
D-Luciferin potassium salt is a water-soluble firefly luciferase substrate for in vivo bioluminescence imaging and in vitro reporter assays. Its ATP-, magnesium-, and oxygen-dependent light reaction supports non-invasive tracking, but signal interpretation depends on reporter expression, substrate delivery, tissue attenuation, and assay controls.
-
ddhCTP: A Mechanism-First Antiviral Assay Guide
2026-09-29
ddhCTP is a biologically generated nucleotide analog that can terminate viral RNA synthesis by selected RNA-dependent RNA polymerases. This guide presents a mechanism-first framework for using ddhCTP in flavivirus studies, HEK293T cell antiviral assays, and experiments distinguishing polymerase inhibition from broader viperin activity.
-
Illuminating GBM Translation with D-Luciferin
2026-09-28
A translational framework for using D-Luciferin potassium salt to quantify luciferase-labeled glioblastoma models, interpret biomaterial responses, and connect longitudinal bioluminescence imaging with mechanistic validation.
-
From RUNX2 to Reliable Samples: Translational Rigor
2026-09-28
A translational perspective on connecting osteoblast mechanism studies with disciplined blood sample preparation. Learn what the trelagliptin–RUNX2 findings establish, where their limits remain, and how selective erythrocyte removal can support separate downstream analyses.
-
Hyaluronic Acid Sodium Salt for siRNA Research
2026-09-27
Explore how high-molecular-weight hyaluronic acid can support extracellular-matrix assays and nanoparticle delivery research, informed by a preclinical study of siRNA treatment for Pseudomonas aeruginosa lung injury. The workflow emphasizes formulation checks, matched controls, and clear separation between published findings and proposed pilot conditions.
-
D-Luciferin Potassium Salt for Imaging Workflows
2026-09-26
D-Luciferin potassium salt supports firefly luciferase readouts in live-cell assays, ATP measurements, and in vivo bioluminescence imaging. This guide connects practical assay design to a cotton plant-defense study while clarifying what a luciferase signal can—and cannot—tell you.
-
4-Phenylbutyric Acid for ER Stress and Autophagy Assays
2026-09-25
Use 4-PBA as a mechanistic rescue tool to test whether ER stress contributes to compound-induced cell death—not as a stand-alone proof of pathway involvement. This workflow connects a liver-cancer study of cytotoxic autophagy to practical dose selection, matched-solvent controls, and orthogonal readouts.
-
EZ Cap™ Firefly Luciferase mRNA for LNP Assays
2026-09-25
Use this Cap 1 reporter to separate mRNA delivery and translation from promoter-driven transcription in cell assays. Its strongest value is comparative: it can help rank delivery conditions in vitro, while recent LNP research shows why those rankings still need careful validation in vivo.
-
CCK-8 Assays for Lung Cancer Research
2026-09-24
Use Cell Counting Kit-8 to track viable-cell metabolic activity during lung cancer experiments, from CCT3 perturbation studies to dose-response testing. A practical 96-well workflow, controls, and troubleshooting tips help distinguish real growth effects from assay interference.
-
CD300LD-Targeted mRNA Vaccines Activate Tumor Neutrophils
2026-09-24
A 2026 study reports a biomimetic mRNA nanovaccine designed to target CD300LD-expressing tumor-associated neutrophils and sustain their activation through IL-36γ expression. In mouse hepatocellular carcinoma models, the formulation was associated with stronger antitumor immunity and a reported survival rate of 85% in the treated group, while key translational questions remain open.
-
Fzd4 N-Glycosylation Enables Wnt/β-Catenin Signaling
2026-09-23
Ji and colleagues identify two conserved N-glycosylation sites in Fzd4 and show that glycosylation supports receptor maturation, stability, cell-surface transport, and signaling. Their findings connect this post-translational modification to NSCLC cell growth and migration, while highlighting receptor processing as an important variable in studies of Wnt signaling.
-
Sulfo-NHS-SS-Biotin for Dynamic Protein Assays
2026-09-23
Sulfo-NHS-SS-Biotin combines aqueous amine labeling with a cleavable disulfide spacer for reversible protein enrichment. This article connects its assay logic to new structural and single-molecule insights into the rice vacuolar phosphate transporter OsVPE2.
-
(Z)-4-Hydroxytamoxifen in Relapse Models
2026-09-22
Use (Z)-4-Hydroxytamoxifen to interrogate estrogen receptor signaling with high-affinity pharmacology, then connect those findings to proliferation, dormancy, and relapse biology. This workflow distinguishes ER-dependent drug response from the low-cycling tumor reservoirs revealed by modern transgenic relapse models.